(Q45400554)

14 December 2017

title

Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice (English)

1 reference

14 December 2017

Juan Zhou

1

1 reference

14 December 2017

Xi-Qiang Yang

2

1 reference

14 December 2017

Yuan-Yuan Xie

3

1 reference

14 December 2017

Xiao-Dong Zhao

4

1 reference

14 December 2017

Li-Ping Jiang

5

1 reference

14 December 2017

Li-Jia Wang

6

1 reference

14 December 2017

Yu-Xia Cui

7

1 reference

14 December 2017

publication date

4 September 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

130

1 reference

14 December 2017

issue

1-2

1 reference

14 December 2017

page(s)

241-248

1 reference

DNAzymes: from creation in vitro to application in vivo.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Prospects of RNA interference therapy in respiratory viral diseases: update 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Inhibition of respiratory viruses by nasally administered siRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Tech.Sight. Molecular biology. Making catalytic DNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Conservation of the respiratory syncytial virus SH gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

The small hydrophobic protein of human respiratory syncytial virus: comparison between antigenic subgroups A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Antisense approaches for inhibiting respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Deoxyribozymes: cleaving a path to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

The role of IFN in respiratory syncytial virus pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Interactions between RSV infection, asthma, and atopy: unraveling the complexities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

A simplified plaque assay for respiratory syncytial virus--direct visualization of plaques without immunostaining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Genetic variability and molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan determined by heteroduplex mobility assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

The pathogenesis of respiratory syncytial virus disease in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Antiviral immune responses and lung inflammation after respiratory syncytial virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Recapitulation of the hairless mouse phenotype using catalytic oligonucleotides: implications for permanent hair removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Basic principles of using antisense oligonucleotides in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

A general purpose RNA-cleaving DNA enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Ribozyme- and deoxyribozyme-strategies for medical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Respiratory syncytial virus genetic and antigenic diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Sequence requirements in the catalytic core of the "10-23" DNA enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2007.06.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2007.06.017

1 reference

14 December 2017

1 reference